Healthcare -
Biotechnology - NASDAQ - US
$ 28.98
-14.9 %
$ 1.88 B
Market Cap
-9.59
P/E
KYMR - REVENUE
Revenue KYMR - Kymera Therapeutics, Inc.
47.1 M
LAST VALUE
0.26%
2 YEAR CAGR
74.20%
5 YEAR CAGR
0.00%
10 YEAR CAGR